Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Japanese encephalitis
SAGE documentation
GRADE table
Clear all
Type of publications
SAGE documentation
(11)
Topics
GRADE table
(11)
Available to download in languages
English (EN)
(11)
Regions
Countries
Diseases
COVID-19
(2)
Japanese encephalitis
(9)
Cholera
(1)
Dengue
(6)
Diphtheria
(1)
Haemophilus influenzae type B
(3)
Hepatitis A
(6)
Human papillomavirus (HPV)
(9)
Measles
(6)
Meningococcal disease
(4)
Pertussis
(2)
Rubella
(1)
Typhoid
(2)
Vaccine topics
Target population
Publication date
2022
(2)
2015
(9)
11 results found
2022
∙
SAGE
Annexes to the interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19
2022
∙
SAGE
Annexes to the interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
2015
∙
SAGE
What is the risk of serious adverse events following vaccination with live attenuated JE vaccine?
2015
∙
SAGE
What is the risk of serious adverse events following vaccination with live recombinant JE vaccine?
2015
∙
SAGE
Is there a need for a booster dose following immunization with one dose of live attenuated JE vaccine in individuals living in JE-endemic areas?
2015
∙
SAGE
Is there a need for a booster dose following immunization with a single dose of live recombinant JE vaccine in vaccinees living in JE-endemic areas?
2015
∙
SAGE
Is there a need for a booster dose following immunization with the primary series of inactivated Vero cell-derived JE vaccine in individuals living in JE-endemic areas?
2015
∙
SAGE
What is the effectiveness of inactivated Vero cell-derived JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
2015
∙
SAGE
What is the effectiveness of live attenuated JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
2015
∙
SAGE
What is the effectiveness of live recombinant JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register